Critical Comparison: Aeon Global Health (OTCMKTS:AGHC) and NeuroOne Medical Technologies (NASDAQ:NMTC)

NeuroOne Medical Technologies (NASDAQ:NMTC) and Aeon Global Health (OTCMKTS:AGHC) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares NeuroOne Medical Technologies and Aeon Global Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-78.34%	-119.92%	-78.86%
Aeon Global Health	N/A	N/A	N/A

Insider & Institutional Ownership

16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 11.8% of NeuroOne Medical Technologies shares are owned by company insiders. Comparatively, 11.5% of Aeon Global Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares NeuroOne Medical Technologies and Aeon Global Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$8.72 million	4.61	-$3.61 million	($0.17)	-4.68
Aeon Global Health	N/A	N/A	N/A	N/A	N/A

Aeon Global Health has lower revenue, but higher earnings than NeuroOne Medical Technologies.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for NeuroOne Medical Technologies and Aeon Global Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1	1	3	0	2.40
Aeon Global Health	0	0	0	0	0.00

NeuroOne Medical Technologies presently has a consensus target price of $1.98, indicating a potential upside of 149.48%. Given NeuroOne Medical Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Aeon Global Health.

Summary

NeuroOne Medical Technologies beats Aeon Global Health on 6 of the 9 factors compared between the two stocks.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

About Aeon Global Health

AEON Global Health Corp. is a growth oriented provider of personalized, actionable medical informatics, and telemedicine. It offers a comprehensive menu of diagnostic and laboratory developed assays, as well as interpretive data for a range of inherited conditions. The company was founded by Hanif A. Roshan and Shawn Desai in August 1985 and is headquartered in Gainesville, GA.